Download to read offline
Transforming capital markets
- 1. Diabetic Nephropathy Diabetic Retinopathy Hypercholesterolemia OralMucositis Gout Acute Lymphocytic Leukemia Bone Metastasis Brain Cancer Breast Cancer Cervical Cancer Chronic Lymphocytic Leukemia Endometrial Cancer Ewing Sarcoma Gastric Cancer Gastrointestinal Stromal Tumors Head And Neck Cancer Hodgkin Lymphoma Kidney Cancer Liver Cancer Malignant Mesothelioma Medullary Thyroid Cancer Melanoma Multiple Myeloma Non-Hodgkin Lymphoma Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Testicular Cancer Thyroid Cancer Age Related Macular Degeneration Keratoconjunctivitis sicca (Dry Eye) Retinal Vein Occlusion Acute Respiratory Distress Syndrome Sepsis Staphylococcal Infections Acute Coronary Syndrome Angina Pectoris Atrial Fibrillation Coronary Artery Disease (CAD) Critical Limb Ischemia Hypertension Pulmonary Arterial Hypertension Acute Pain Anxiety Disorders Chronic Pain Dementia Diabetic Neuropathy Obsessive-Compulsive Disorder Osteoarthritis Pain Parkinson's Disease Post-Traumatic Stress Disorder Restless Legs Syndrome Schizophrenia Traumatic Brain Injury Liver Cirrhosis Childhood Enuresis Growth Hormone Disorders Hyperparathyroidism Hyperthyroidism Guillain-Barre Syndrome Cytomegalovirus Fungal Infections Gram-Negative Bacterial Infections H1N1 Infection Herpes Zoster HIV-1 Infection Human Papillomavirus Infections Staphylococcus Aureus (MRSA) Cardiovascular Devices Prosthetic Heart Valve Peripheral Vascular Devices Cardiovascular Monitoring & Diagnostic Devices Cardiovascular Surgery Cardiac Rhythm Management Cardiovascular Prosthetic Devices Interventional Cardiology Cardiac Assist Devices Wound Care Management Hospital Supplies Syringes and Needles Disposable Hospital & Surgical Supplies Drug Delivery Devices Inhalation Systems Needle Free Injections Infusion Systems Diabetes Care Devices Insulin Delivery & Glucose Monitoring Ophthalmic Devices Cataract Surgery Devices Ophthalmic Diagnostic Equipment Refractive Surgery Devices ENT Devices Hearing Implants Diagnostic Devices Electrosurgical Devices Dental Equipment & Accessories Diagnostic Imaging & MRI Systems C/T Systems & Mammography Equipment X-Ray & Ultrasound Systems Nuclear Imaging Equipment Contrast Media Injectors Bone Densitometry Anesthesia and Respiratory Devices Anesthesia Machines & Disposables Respiratory Devices & Disposables Sleep Apnea Diagnostic Systems Healthcare IT Medical Imaging Information Systems Nephrology and Urology Devices Renal Dialysis Equipment Orthopedic Devices Orthobiologics & Arthroscopy Joint Reconstruction Trauma Fixation Orthopedic Prosthetics Cranium Maxillofacial Fixation (CMF) Spinal Surgery Endoscopy Devices & instruments Rigid & Flexible Endoscope In Vitro Diagnostics Genetic Testing Clinical Chemistry Hematology Immuno Chemistry Infectious Immunology Histology And Cytology Patient Monitoring Multiparameter Patient Monitoring Micro-Electromechanical Systems Non-invasive Blood Pressure Monitors Neurology Devices Neurostimulation Devices Interventional Neurology CSF Management Neurosurgical Products Radiosurgery Transforming Healthcare Capital Markets
- 2. Healthcare’s Investment Marketplace Discovery Develop- mentI N D PhaseI PhaseII PhaseIII N D A Approval Launch Growth Mature Healthcare Development & Financing Cycle IPO / Public MarketsVenture CapitalAngels / Founders Private Equity / M&A SEED EXIT … E M E R G I N G G R O W T H C O M PA N I E S … ‘ L E A D ’ I N V E S T O R S … D I R E C T I N V E S T O R S … S T R AT E G I C PA RT N E R S & B U Y E R S T R A N S F O R M I N G H E A LT H C A R E C A P I TA L M A R K E T S on behalf of…
- 3. Healthcare’s Investment Bank SuperiorOutcomes 1. Reduce Risk 2. Enhance Returns 3. Expand Access to Capital 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events 6,000 + Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
- 4. Healthcare’s Investment Bank SuperiorOutcomes Reducing Risk 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events 6,000 + Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
- 5. Healthcare’s Investment Bank SuperiorOutcomes Enhance Returns 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events 6,000 + Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
- 6. Healthcare’s Investment Bank SuperiorOutcomes Expand Access to Capital 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events 6,000 + Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
- 7. Healthcare’s Investment Bank SuperiorOutcomes 1. Reduce Risk 2. Heighten Returns 3. Expand Access to Capital 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events 6,000 + Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
Editor's Notes
- #3 All-at-once, the global healthcare industry is the most complex, chaotic, compelling and dynamic market in the world. A $3 trillion global industry, growing 16% annually, capitalizing itself $13.8 million at a time through more than 9,000 negotiated transactions in 6,000 companies into which, on average, $49 million of capital is deployed over 6.2 years, yielding a “Cash-on-Cash” returns of 4.1x and IRR’s of 22.1% while generating 81% liquidity on invested capital through 892 “Exit” events, of which 87% are M&A. HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. By aggregating 6,000 Emerging Growth healthcare companies in (37) countries together with 30,000 investors in (10) asset classes and 2,000 strategic partners representing (46) market sectors IN A SINGLE MARKET ENVIRONMENT, HealthiosXchange represents a universal capital markets experience perfectly reflective of the industry it serves. Among our most important goals is to: Transform the manner in which capital is invested – and value is realized – throughout the global healthcare industry.
- #4 HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. We intend to transform the manner in which capital is invested – and value is realized – throughout the global healthcare industry by: Reducing the risk of healthcare investing Generating superior returns for investors Expanding access to capital for the most promising Emerging Growth companies.
- #5 HealthiosXchange aggregates 6,000 Emerging Growth healthcare companies in (37) countries together with 30,000 investors in (10) asset classes and 2,000 strategic partners representing (46) market sectors, IN A SINGLE MARKET ENVIRONMENT. The scale of HealthiosXchange allows it to reduce the risk for healthcare investors by: Providing the broadest, most dynamic ACCESS to the fastest growing, most compelling market in the world. Promoting the highest standards of investment DIVERSIFICATION, while reducing Correlation and minimizing Adverse selection in investors’ portfolios Maximizing TRANSPARENCY throughout the investment horizon, by standardizing reporting and communications in an effort to assist Xchange participants in making better financing, investment and strategic decisions, HealthiosXchange is also incorporating proprietary “Big Data” analytics assimilating 18 million data points encompassing healthcare investment history since 1985.
- #6 HealthiosXchange controls 100% of its transaction origination, which enables extraordinary flexibility in administering the investment process. With this flexibility, HealthiosXchange can enhance returns & IRR for investors by: Offering all investments on a “No Fee, No Carry” basis. Shortening the investment period by allowing capital to be deployed directly into the Company only when it is needed Accelerating liquidity by returning capital to investors immediately upon the realization of that Company’s “exit” event In addition, HealthiosXchange has set forth standards – or “Rule Sets” – through which direct investors can maximize the consistency of their healthcare portfolio while engendering the confidence necessary to maximize their investment outcome throughout the “Exit’ horizon.
- #7 By reducing the risk of healthcare investing, mitigating its costs and promoting enhanced investment returns, HealthiosXchange is creating new incentives for capital to be invested in healthcare and – in the process – expanding access to capital for the most promising emerging growth healthcare companies in the world.
- #8 Reduce Risk… Heighten Returns… Expand Access to Capital… In themselves, any one of these benefits could be transformative on their own… Yet, the promise of HealthiosXchange lies in a capital markets experience which accomplishes all of these objectives. Welcome to Healthcare’s Investment Marketplace.